Yao Shen

4.4k total citations · 1 hit paper
69 papers, 3.0k citations indexed

About

Yao Shen is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yao Shen has authored 69 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Pharmacology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yao Shen's work include Inflammatory mediators and NSAID effects (10 papers), Estrogen and related hormone effects (7 papers) and Prostate Cancer Treatment and Research (6 papers). Yao Shen is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Estrogen and related hormone effects (7 papers) and Prostate Cancer Treatment and Research (6 papers). Yao Shen collaborates with scholars based in United States, China and France. Yao Shen's co-authors include Alice C. Levine, Alexander Kirschenbaum, Xinhua Liu, James F. Holland, Andrea Califano, Mariano J. Alvarez, Alexander Lachmann, Federico M. Giorgi, B. Hilda Ye and B. Belinda Ding and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yao Shen

62 papers receiving 2.9k citations

Hit Papers

Functional characterization of somatic mutations in cance... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yao Shen United States 25 1.2k 1.0k 648 550 439 69 3.0k
Michihiro Mutoh Japan 33 2.2k 1.8× 937 0.9× 482 0.7× 954 1.7× 1.4k 3.2× 168 4.8k
Imad Shureiqi United States 34 1.7k 1.4× 970 0.9× 467 0.7× 914 1.7× 1.0k 2.4× 80 3.6k
Graham P. Pidgeon Ireland 29 1.0k 0.9× 541 0.5× 191 0.3× 656 1.2× 635 1.4× 65 2.7k
Gary J. Kelloff United States 22 661 0.6× 729 0.7× 687 1.1× 402 0.7× 471 1.1× 32 2.1k
Clinton J. Grubbs United States 38 2.5k 2.1× 515 0.5× 1.3k 2.0× 663 1.2× 905 2.1× 138 4.4k
Sisko Anttila Finland 36 2.1k 1.8× 545 0.5× 705 1.1× 1.3k 2.3× 950 2.2× 91 4.6k
Nicola Maggiano Italy 32 1.1k 0.9× 386 0.4× 340 0.5× 449 0.8× 305 0.7× 81 3.1k
Maen Abdelrahim United States 40 2.7k 2.3× 396 0.4× 598 0.9× 1.0k 1.8× 1.3k 2.9× 157 5.2k
Chin‐Wen Chi Taiwan 32 1.5k 1.2× 670 0.6× 195 0.3× 598 1.1× 509 1.2× 80 3.0k
Laura Calabresi Italy 49 2.2k 1.8× 299 0.3× 326 0.5× 1.2k 2.2× 592 1.3× 230 7.7k

Countries citing papers authored by Yao Shen

Since Specialization
Citations

This map shows the geographic impact of Yao Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Shen more than expected).

Fields of papers citing papers by Yao Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Shen. The network helps show where Yao Shen may publish in the future.

Co-authorship network of co-authors of Yao Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yao Shen. A scholar is included among the top collaborators of Yao Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao Shen. Yao Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Yao, et al.. (2025). Design and application of a water-soluble triphenylamine-based probe for rapid analysis of α-amylase activity. Bioorganic Chemistry. 159. 108420–108420. 1 indexed citations
5.
Feng, Lin, Biao Tang, Zhiyu Li, et al.. (2024). Acinetobacter indicus Coharboring Tet(X6) and blaNDM-1 Isolated From Slaughterhouse Waste. Journal of Global Antimicrobial Resistance. 41. 1–7. 1 indexed citations
7.
Chen, Yifang, et al.. (2023). Asperaldehyde, A New Conjugated Compound from the Marine-Derived Fungus Aspergillus sp. LPFH-6. Records of Natural Products. 664–670. 1 indexed citations
8.
Zhou, Yanli, et al.. (2023). A New Sesquiterpene and Two Nitro-containing Phenylpropionic Acid Derivatives from the Fungus Aspergillus terreus LPFH-1. Records of Natural Products. 516–521. 2 indexed citations
9.
Zhang, Qiuqin, Yifang Chen, Ming‐Hua Xie, et al.. (2022). Mechanochemical preparation of triptolide-loaded self-micelle solid dispersion with enhanced oral bioavailability and improved anti-tumor activity. Drug Delivery. 29(1). 1398–1408. 15 indexed citations
10.
Lassman, Andrew B., Patrick Y. Wen, Martin J. van den Bent, et al.. (2021). A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma. Clinical Cancer Research. 28(3). 452–460. 40 indexed citations
11.
Landsburg, Daniel J., Stefan K. Barta, Radhakrishnan Ramchandren, et al.. (2021). Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses. British Journal of Haematology. 195(2). 201–209. 30 indexed citations
12.
Walker, Christopher J., Yao Shen, Mariano J. Alvarez, et al.. (2020). A Six-Protein Activity Signature Defines Favorable Response to Selinexor Treatment for Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 136(Supplement 1). 31–32. 1 indexed citations
13.
Yu, Yongquan, Yao Shen, Yan Lu, et al.. (2018). Acute effects of air pollution on ischaemic stroke onset and deaths: a time-series study in Changzhou, China. BMJ Open. 8(7). e020425–e020425. 44 indexed citations
14.
Davé, Utpal P., Irina V. Lebedeva, Yao Shen, et al.. (2017). PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature. Molecular Cancer Therapeutics. 16(10). 2069–2082. 7 indexed citations
15.
Bisikirska, Brygida, Mukesh Bansal, Yao Shen, et al.. (2015). Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression. Cancer Research. 76(3). 664–674. 37 indexed citations
16.
Shen, Yao, et al.. (2010). Screening of Enzyme Inhibitors from Traditional Chinese Medicine. Combinatorial Chemistry & High Throughput Screening. 13(10). 885–899. 8 indexed citations
17.
Chen, Yingzhuang, Guozhu Liu, Yao Shen, Bo Chen, & Jianguo Zeng. (2008). Analysis of alkaloids in Macleaya cordata (Willd.) R. Br. using high-performance liquid chromatography with diode array detection and electrospray ionization mass spectrometry. Journal of Chromatography A. 1216(11). 2104–2110. 49 indexed citations
18.
Kirschenbaum, Alexander, Xinhua Liu, Yao Shen, et al.. (2005). Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. Carcinogenesis. 27(2). 216–224. 16 indexed citations
19.
Liu, Xinhua, Alexander Kirschenbaum, Yao Shen, et al.. (1999). Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clinical & Experimental Metastasis. 17(8). 687–694. 141 indexed citations
20.
Liu, Xinhua, Yao Shen, Alexander Kirschenbaum, & Alice C. Levine. (1998). NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.. PubMed. 58(19). 4245–9. 391 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026